BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28624570)

  • 1. Effects of intrauterine contraception on the vaginal microbiota.
    Bassis CM; Allsworth JE; Wahl HN; Sack DE; Young VB; Bell JD
    Contraception; 2017 Sep; 96(3):189-195. PubMed ID: 28624570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal microbiome changes with levonorgestrel intrauterine system placement.
    Jacobson JC; Turok DK; Dermish AI; Nygaard IE; Settles ML
    Contraception; 2014 Aug; 90(2):130-5. PubMed ID: 24835828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial.
    Kakaire O; Tumwesigye NM; Byamugisha JK; Gemzell-Danielsson K
    Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):220-6. PubMed ID: 26895345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system.
    Simonatto P; Bahamondes MV; Fernandes A; Silveira C; Bahamondes L
    J Obstet Gynaecol Res; 2016 May; 42(5):554-9. PubMed ID: 26817571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study.
    Kaislasuo J; Suhonen S; Gissler M; Lähteenmäki P; Heikinheimo O
    Hum Reprod; 2012 Sep; 27(9):2658-63. PubMed ID: 22763376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid-based cervical cytology and microbiological analyses in women using cooper intrauterine device and levonorgestrel-releasing intrauterine system.
    Eleuterio J; Giraldo PC; Silveira Gonçalves AK; Nunes Eleuterio RM
    Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():20-24. PubMed ID: 33065517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-hormonal and hormonal intrauterine contraception: survey of patients' perceptions in four Latin American countries.
    Silva-Filho AL; Lira J; Rocha AL; Ferreira MC; Lamaita RM; Cândido EB; Carneiro MM
    Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):213-9. PubMed ID: 26848851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term influence of the levonorgestrel-releasing intrauterine system (Mirena®) on vaginal microbiota and Candida.
    Donders GGG; Bellen G; Ruban K; Van Bulck B
    J Med Microbiol; 2018 Mar; 67(3):308-313. PubMed ID: 29458551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levonorgestrel-releasing intrauterine system is associated with delayed endocervical clearance of Chlamydia trachomatis without alterations in vaginal microbiota.
    Liechty ER; Bergin IL; Bassis CM; Chai D; LeBar W; Young VB; Bell JD
    Pathog Dis; 2015 Nov; 73(8):ftv070. PubMed ID: 26371177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
    Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
    Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in body composition in women using long-acting reversible contraception.
    Silva Dos Santos PN; Madden T; Omvig K; Peipert JF
    Contraception; 2017 Apr; 95(4):382-389. PubMed ID: 28041992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use.
    Modesto W; de Nazaré Silva dos Santos P; Correia VM; Borges L; Bahamondes L
    Eur J Contracept Reprod Health Care; 2015 Feb; 20(1):57-63. PubMed ID: 25160484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of contraceptive initiation on vaginal microbiota.
    Achilles SL; Austin MN; Meyn LA; Mhlanga F; Chirenje ZM; Hillier SL
    Am J Obstet Gynecol; 2018 Jun; 218(6):622.e1-622.e10. PubMed ID: 29505773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of copper-containing and levonorgestrel-releasing intrauterine contraceptives on cervicovaginal cytology and microbiological flora: a prospective study.
    Erol O; Simavlı S; Derbent AU; Ayrım A; Kafalı H
    Eur J Contracept Reprod Health Care; 2014 Jun; 19(3):187-93. PubMed ID: 24738915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception.
    Achilles SL; Chen BA; Lee JK; Gariepy AM; Creinin MD
    Contraception; 2015 Dec; 92(6):572-4. PubMed ID: 26297203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.